EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Amedisys's Enterprise Value is $3,334 Mil.
Amedisys's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $71 Mil. Therefore, Amedisys's EV-to-EBIT for today is 47.02.
The historical rank and industry rank for Amedisys's EV-to-EBIT or its related term are showing as below:
AMED'
s EV-to-EBIT Range Over the Past 10 Years
Min: -238.53 Med: 25.02 Max: 2473.61
Current: 47.02
During the past 13 years, the highest EV-to-EBIT of Amedisys was 2473.61. The lowest was -238.53. And the median was 25.02.
AMED's EV-to-EBIT is ranked worse than 87.12% of 427
companies
in the Healthcare Providers & Services industry
Industry Median: 18.27
vs AMED: 47.02
The historical data trend for Amedisys's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Amedisys Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-EBIT
30.75
44.41
20.05
17.91
49.64
Amedisys Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBIT
17.91
16.22
46.06
43.60
49.64
Competitive Comparison
For the Medical Care Facilities subindustry, Amedisys's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amedisys EV-to-EBIT Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Amedisys's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Amedisys's EV-to-EBIT falls into.
Amedisys's current Enterprise Value is $3,334 Mil.
Amedisys's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amedisys (NAS:AMED) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Amedisys's Enterprise Value for the quarter that ended in Dec. 2023 was $3,519 Mil.
Amedisys's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amedisys EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Amedisys's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMED has been successfully added to your 